Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cascades Reports Results for the First Quarter of 2023


      News provided by

      Cascades Inc.

      May 11, 2023, 06:00 ET

      Share this article

      Share this article


      Starting the year with solid results

      KINGSEY FALLS, QC, May 11, 2023 /PRNewswire/ - Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended March 31, 2023.

      Q1 2023 Highlights

      • Sales of $1,134 million (compared with $1,135 million in Q4 2022 and $1,038 million in Q1 2022)
      • Operating loss of $(80) million (compared with $(20) million in Q4 2022 and $(4) million in Q1 2022)
      • Net loss per common share of ($0.75) (compared with a net loss per common share of ($0.27) in Q4 2022 and a net loss per common share of ($0.15) in Q1 2022)
      • Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A)1) of $134 million (compared with $116 million in Q4 2022 and $58 million in Q1 2022)
      • Adjusted net earnings per common share1 of $0.32 (compared with adjusted net earnings per common share1 of $0.22 in Q4 2022 and a adjusted net loss per common share1 of ($0.15) in Q1 2022)
      • Net debt1 of $2,070 million as of March 31, 2023 (compared with $1,966 million as of December 31, 2022). Net debt to EBITDA (A) ratio1 of 4.6x, down from 5.2x as of December 31, 2022.
      • Total capital expenditures, net of disposals, of $137 million in Q1 2023, compared to $149 million in Q4 2022 and to $96 million in Q1 2022. The Corporation's 2023 forecasted net capital expenditures of approximately $325 million, including $175 million ($100 million of which was paid in Q1) for the Bear Island containerboard conversion project in Virginia, USA, is unchanged.

      Mario Plourde, President and CEO, commented: "We had a solid first quarter. All three businesses contributed to topline growth year-over-year, as benefits from higher selling prices and an advantageous exchange rate more than offset the impacts of a less favourable mix in Containerboard and lower volumes in Tissue Papers and Specialty Products. Higher sales, notably in Tissue, and lower raw material costs in our packaging businesses drove higher consolidated profitability levels. Sequentially, sales were stable, with stronger volumes in all businesses counterbalancing the impacts of less favourable sales mixes in Containerboard and Tissue and lower selling prices in our packaging businesses. Containerboard results include the final insurance settlement payment of $7 million related to water effluent treatment issues that occurred at our Niagara Falls, NY complex in mid-2021, bringing the insurance settlement total to $12 million.

      We announced an important repositioning of our Tissue Papers operational platform at the end of April. This decision, which was not taken lightly due to its impact on our work force, is the culmination of an in-depth evaluation of the long-term positioning, competitiveness and performance potential of our tissue operations following disappointing results in recent years. Market conditions in this business have changed significantly, and the closure of these underperforming assets will strengthen not only the operational performance of this business, but its financial and environmental performance as well. In our Containerboard segment, we are very pleased to have announced that the Bear Island facility produced its first containerboard roll at the beginning of May. We provide more details on these positive announcements and what they mean for Cascades' longer-term objectives in our updated 2022 - 2024 Strategic Plan released today. From a consolidated perspective, our 2024 revenue target of approximately $5 billion remains unchanged, and our EBITDA (A) and free cash flow objectives have been slightly modified to reflect the announced changes to our operational platform and updated market forecasts. As a result of the lower cash generation levels of 2022 and higher Bear Island project cost, the Corporation has adjusted its leverage ratio objective to 2.5x to 3.0x by year-end 2024. The Corporation's capital allocation priorities will focus on debt repayment while limiting capital expenditures to 4% of revenues through 2024. Combined, this focus will support the Company's mid-term leverage ratio objective of 2.0x to 2.5x ."

      1 Some information represents Non-IFRS financial measures, other financial measures or Non-IFRS ratios which are not standardized under IFRS and therefore might not be comparable to similar financial measures disclosed by other corporations. Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation.


      Discussing near-term outlook, Mr. Plourde commented, "On a consolidated basis, we are expecting slightly lower results in the second quarter, with lower results in our packaging businesses to offset forecasted stronger results in our Tissue Papers business. In Containerboard, this outlook reflects slightly softer demand, changes in index prices for raw materials and selling prices, and the non-recurrence of the $7 million final insurance settlement received in Q1. We are expecting similar results for our Specialty Products segment, with relatively stable volume, pricing and raw material costs. Lastly, we expect results in our Tissue Papers segment to improve sequentially driven by the additional benefits from profitability initiatives, higher selling prices, lower raw material costs and stable demand."

      Financial Summary

      Selected consolidated information

      (in millions of Canadian dollars, except amounts per common share) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022





      Sales

      1,134

      1,135

      1,038

      As Reported




      Operating loss

      (80)

      (20)

      (4)

      Net loss

      (75)

      (27)

      (15)

      per common share (basic)

      ($0.75)

      ($0.27)

      ($0.15)

      Adjusted1




      Earnings before interest, taxes, depreciation and amortization (EBITDA (A))

      134

      116

      58

      Net earnings (loss)

      33

      22

      (15)

      per common share (basic)

      $0.32

      $0.22

      ($0.15)

      Margin EBITDA (A)

      11.8 %

      10.2 %

      5.6 %


      Segmented sales

      (in millions of Canadian dollars) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022





      Packaging Products




      Containerboard

      561

      567

      534

      Specialty Products

      161

      161

      157

      Inter-segment sales

      (7)

      (7)

      (8)


      715

      721

      683

      Tissue Papers

      387

      384

      314

      Inter-segment sales, Corporate Activities, Recovery and Recycling

      32

      30

      41

      Sales

      1,134

      1,135

      1,038


      Segmented operating income (loss)

      (in millions of Canadian dollars) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022





      Packaging Products




      Containerboard

      38

      85

      44

      Specialty Products

      21

      22

      24





      Tissue Papers

      (92)

      (86)

      (35)





      Corporate Activities, Recovery and Recycling

      (47)

      (41)

      (37)

      Operating income (loss)

      (80)

      (20)

      (4)

      Segmented EBITDA (A)1

      (in millions of Canadian dollars) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022





      Packaging Products




      Containerboard

      126

      119

      80

      Specialty Products

      27

      20

      22





      Tissue Papers

      16

      8

      (17)





      Corporate Activities, Recovery and Recycling

      (35)

      (31)

      (27)

      EBITDA (A)1

      134

      116

      58


      1 Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation


      Analysis of results for the three-month period ended March 31, 2023 (compared to the same period last year)
      Sales of $1,134 million increased by $96 million compared with the same period last year. This reflects a net benefit of $76 million that was driven by higher selling prices in all business segments, partially offset by a slightly negative consolidated sales mix impact. The Canadian dollar - US dollar exchange rate was favourable for all businesses, contributing $47 million to total sales levels. These factors were partially offset by a $19 million impact related to lower volumes in the Tissue Papers and Specialty Products business segments.

      The first quarter EBITDA (A)1 totaled $134 million, an increase of $76 million, or 131%, from the $58 million generated in the same period last year. This increase reflects the net benefits of $72 million related to price increases and changes in sales volumes and product assortment sold, and $44 million from more favourable raw material and FX. These benefits outweighed a net impact of $28 million related to production, logistics and energy costs and a $12 million negative contribution from Recovery and Recycling operations as a result of lower volume and recycled paper prices.

      The main specific items, before income taxes, that impacted our first quarter 2023 operating loss and/or net loss were:

      • $152 million of impairment charges on US assets (operating loss and net loss);
      • $2 million gain from the sale of some machinery and equipment and $1 million of restructuring costs related to previously closed Tissue Papers plants in the US (operating loss and net loss);
      • $1 million unrealized loss on financial instruments (operating loss and net loss);
      • $9 million gain from the sale of an investment in a non-significant joint venture in the Tissue Papers segment (net loss).

      For the three-month period ended March 31, 2023, the Corporation posted a net loss of $(75) million, or $(0.75) per common share, compared to a net loss of $(15) million, or $(0.15) per common share, in the same period of 2022. On an adjusted basis1, the Corporation generated net earnings of $33 million in the first quarter of 2023, or $0.32 per common share, compared to a net loss of $(15) million, or ($0.15) per common share, in the same period of 2022.

      1 Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation.


      Dividend on common shares and normal course issuer bid
      The Board of Directors of Cascades declared a quarterly dividend of $0.12 per common share to be paid on June 8, 2023 to shareholders of record at the close of business on May 26, 2023. This dividend is an "eligible dividend" as per the Income Tax Act (R.C.S. (1985), Canada). During the first quarter of 2023, Cascades purchased no common shares for cancellation.

      2023 First Quarter Results Conference Call Details
      Management will discuss the 2023 first quarter financial results during a conference call today at 9:00 a.m. EDT. The call can be accessed by dialing 1-888-390-0620 (international 1-416-764-8651). The conference call, including the investor presentation, will be broadcast live on the Cascades website (www.cascades.com) under the "Investors" section. A replay of the call will be available on the Cascades website and may also be accessed by phone until June 11, 2023 by dialing 1-888-390-0541 (international 1-416-764-8677), access code 690640.

      Founded in 1964, Cascades offers sustainable, innovative and value-added packaging, hygiene and recovery solutions. The company employs approximately 10,000 women and men across a network of close to 80 facilities in North America. Driven by its participative management, half a century of experience in recycling, and continuous research and development efforts, Cascades continues to provide innovative products that customers have come to rely on, while contributing to the well-being of people, communities and the entire planet. Cascades' shares trade on the Toronto Stock Exchange under the ticker symbol CAS. Certain statements in this release, including statements regarding future results and performance, are forward-looking statements based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation's products, increases in raw material costs, fluctuations in selling prices and adverse changes in general market and industry conditions and other factors.

      CONSOLIDATED BALANCE SHEETS

      (in millions of Canadian dollars) (unaudited)

      March 31,
      2023

      December 31,
      2022

      Assets



      Current assets



      Cash and cash equivalents

      64

      102

      Accounts receivable

      546

      556

      Current income tax assets

      10

      11

      Inventories

      614

      587

      Current portion of financial assets

      5

      9


      1,239

      1,265

      Long-term assets



      Investments in associates and joint ventures

      95

      94

      Property, plant and equipment

      2,857

      2,945

      Intangible assets with finite useful life

      69

      73

      Financial assets

      3

      4

      Other assets

      72

      70

      Deferred income tax assets

      147

      114

      Goodwill and other intangible assets with indefinite useful life

      488

      488


      4,970

      5,053

      Liabilities and Equity



      Current liabilities



      Bank loans and advances

      2

      3

      Trade and other payables

      673

      746

      Current income tax liabilities

      4

      4

      Current portion of long-term debt

      88

      134

      Current portion of provisions for contingencies and charges

      7

      8

      Current portion of financial liabilities and other liabilities

      26

      22


      800

      917

      Long-term liabilities



      Long-term debt

      2,044

      1,931

      Provisions for contingencies and charges

      41

      41

      Financial liabilities

      9

      7

      Other liabilities

      98

      97

      Deferred income tax liabilities

      136

      132


      3,128

      3,125

      Equity



      Capital stock

      611

      611

      Contributed surplus

      15

      14

      Retained earnings

      1,126

      1,212

      Accumulated other comprehensive income

      28

      34

      Equity attributable to Shareholders

      1,780

      1,871

      Non-controlling interests

      62

      57

      Total equity

      1,842

      1,928


      4,970

      5,053


      CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)


      For the 3-month periods ended
      March 31,

      (in millions of Canadian dollars, except per common share amounts and number of common shares) (unaudited)

      2023

      2022

      Sales

      1,134

      1,038




      Supply chain and logistic

      663

      667

      Wages and employee benefits expenses

      273

      241

      Depreciation and amortization

      62

      60

      Maintenance and repair

      58

      56

      Other

      6

      16

      Impairment charges

      152

      —

      Gain on acquisitions, disposals and others

      (2)

      (6)

      Restructuring costs

      1

      1

      Unrealized loss on derivative financial instruments

      1

      7

      Operating loss

      (80)

      (4)

      Financing expense

      23

      15

      Share of results of associates and joint ventures

      (12)

      (4)

      Loss before income taxes

      (91)

      (15)

      Recovery of income taxes

      (24)

      (4)

      Net loss including non-controlling interests for the period

      (67)

      (11)

      Net earnings attributable to non-controlling interests

      8

      4

      Net earnings (loss) attributable to Shareholders for the period

      (75)

      (15)

      Net loss per common share



      Basic

      ($0.75)

      ($0.15)

      Diluted

      ($0.75)

      ($0.15)

      Weighted average basic number of common shares outstanding

      100,361,627

      100,822,921

      Weighted average number of diluted common shares

      100,701,239

      101,608,760


      CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)


      For the 3-month periods ended
      March 31,

      (in millions of Canadian dollars) (unaudited)

      2023

      2022

      Net loss including non-controlling interests for the period

      (67)

      (11)

      Other comprehensive income (loss)



      Items that may be reclassified subsequently to earnings



      Translation adjustments



      Change in foreign currency translation of foreign subsidiaries

      (2)

      (11)

      Change in foreign currency translation related to net investment hedging activities

      1

      3

      Cash flow hedges



      Change in fair value of commodity derivative financial instruments

      (6)

      6

      Recovery of (provision for) income taxes

      1

      (2)


      (6)

      (4)

      Items that are not released to earnings



      Actuarial gain on employee future benefits

      1

      19

      Provision for income taxes

      —

      (5)


      1

      14

      Other comprehensive income (loss)

      (5)

      10

      Comprehensive loss including non-controlling interests for the period

      (72)

      (1)

      Comprehensive income attributable to non-controlling interests for the period

      8

      4

      Comprehensive loss attributable to Shareholders for the period

      (80)

      (5)


      CONSOLIDATED STATEMENTS OF EQUITY


      For the 3-month period ended March 31, 2023

      (in millions of Canadian dollars) (unaudited)

      CAPITAL STOCK

      CONTRIBUTED
      SURPLUS

      RETAINED
      EARNINGS

      ACCUMULATED
      OTHER
      COMPREHENSIVE
      INCOME

      TOTAL EQUITY
      ATTRIBUTABLE TO
      SHAREHOLDERS

      NON-
      CONTROLLING
      INTERESTS

      TOTAL EQUITY

      Balance - Beginning of period

      611

      14

      1,212

      34

      1,871

      57

      1,928

      Comprehensive income (loss)








      Net earnings (loss)

      —

      —

      (75)

      —

      (75)

      8

      (67)

      Other comprehensive income (loss)

      —

      —

      1

      (6)

      (5)

      —

      (5)


      —

      —

      (74)

      (6)

      (80)

      8

      (72)

      Dividends

      —

      —

      (12)

      —

      (12)

      (3)

      (15)

      Stock options expense

      —

      1

      —

      —

      1

      —

      1

      Balance - End of period

      611

      15

      1,126

      28

      1,780

      62

      1,842










      For the 3-month period ended March 31, 2022

      (in millions of Canadian dollars) (unaudited)

      CAPITAL STOCK

      CONTRIBUTED
      SURPLUS

      RETAINED
      EARNINGS

      ACCUMULATED
      OTHER
      COMPREHENSIVE
      LOSS

      TOTAL EQUITY
      ATTRIBUTABLE TO
      SHAREHOLDERS

      NON-
      CONTROLLING
      INTERESTS

      TOTAL EQUITY

      Balance - Beginning of period

      614

      14

      1,274

      (23)

      1,879

      48

      1,927

      Comprehensive income (loss)








      Net earnings (loss)

      —

      —

      (15)

      —

      (15)

      4

      (11)

      Other comprehensive income (loss)

      —

      —

      14

      (4)

      10

      —

      10


      —

      —

      (1)

      (4)

      (5)

      4

      (1)

      Dividends

      —

      —

      (12)

      —

      (12)

      (4)

      (16)

      Redemption of common shares

      (2)

      —

      (3)

      —

      (5)

      —

      (5)

      Balance - End of period

      612

      14

      1,258

      (27)

      1,857

      48

      1,905


      CONSOLIDATED STATEMENTS OF CASH FLOWS


      For the 3-month periods ended
      March 31,

      (in millions of Canadian dollars) (unaudited)

      2023

      2022

      Operating activities



      Net loss attributable to Shareholders for the period

      (75)

      (15)

      Adjustments for:



      Financing expense

      23

      15

      Depreciation and amortization

      62

      60

      Impairment charges

      152

      —

      Gain on acquisitions, disposals and others

      (2)

      (6)

      Restructuring costs

      1

      1

      Unrealized loss on derivative financial instruments

      1

      7

      Recovery of income taxes

      (24)

      (4)

      Share of results of associates and joint ventures

      (12)

      (4)

      Net earnings attributable to non-controlling interests

      8

      4

      Net financing expense paid

      (44)

      (30)

      Net income taxes paid

      (2)

      (1)

      Dividends received

      1

      —

      Provisions for contingencies and charges and other liabilities

      —

      (8)


      89

      19

      Changes in non-cash working capital components

      (46)

      (92)


      43

      (73)

      Investing activities



      Disposals in associates and joint ventures

      10

      —

      Payments for property, plant and equipment

      (140)

      (102)

      Proceeds from disposals of property, plant and equipment

      3

      6

      Change in intangible and other assets

      (2)

      (1)


      (129)

      (97)

      Financing activities



      Bank loans and advances

      (1)

      6

      Change in credit facilities

      122

      57

      Payments of other long-term debt, including lease obligations

      (57)

      (9)

      Redemption of common shares

      —

      (5)

      Dividends paid to non-controlling interests

      (3)

      (4)

      Dividends paid to the Corporation's Shareholders

      (12)

      (12)


      49

      33

      Net change in cash and cash equivalents during the period

      (37)

      (137)

      Currency translation on cash and cash equivalents

      (1)

      —

      Cash and cash equivalents - Beginning of the period

      102

      174

      Cash and cash equivalents - End of the period

      64

      37


      SEGMENTED INFORMATION

      The Corporation's operations are managed in three segments: Containerboard and Specialty Products (which constitutes the Corporation's Packaging Products) and Tissue Papers. The accounting policies of the reportable segments are the same as the Corporation's accounting policies described in Note 2.

      The Corporation's operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker (CODM). The Chief Executive Officer has authority for resource allocation and management of the Corporation's performance and is therefore the CODM. The CODM assesses the performance of each reportable segment based on sales and earnings before interest, taxes, depreciation and amortization, adjusted to exclude specific items (EBITDA (A)). The CODM considers EBITDA (A) to be the best performance measure of the Corporation's activities.

      Sales for each segment are prepared on the same basis as those of the Corporation. Inter-segment operations are recorded on the same basis as sales to third parties, which are at fair market value.

      EBITDA (A) does not have a standardized meaning under IFRS; accordingly, it may not be comparable to similarly named measures used by other companies. Investors should not view EBITDA (A) as an alternative measure to, for example, net earnings, or as a measure of operating results, which are IFRS measures.








      SALES TO




      For the 3-month periods ended March 31,


      Canada

      United States

      Other countries

      Total

      (in millions of Canadian dollars) (unaudited)

      2023

      2022

      2023

      2022

      2023

      2022

      2023

      2022

      Packaging Products









      Containerboard

      329

      328

      231

      206

      1

      —

      561

      534

      Specialty Products

      56

      57

      104

      100

      1

      —

      161

      157

      Inter-segment sales

      (4)

      (4)

      (3)

      (4)

      —

      —

      (7)

      (8)


      381

      381

      332

      302

      2

      —

      715

      683

      Tissue Papers

      126

      95

      261

      219

      —

      —

      387

      314

      Inter-segment sale, Corporate Activities, Recovery and Recycling

      25

      37

      6

      4

      1

      —

      32

      41


      532

      513

      599

      525

      3

      —

      1,134

      1,038


      The reconciliation of operating income (loss) to EBITDA (A) by business segment is as follows:


      For the 3-month period ended March 31, 2023

      (in millions of Canadian dollars) (unaudited)

      Containerboard

      Specialty
      Products

      Tissue
      Papers

      Corporate
      Activities,
      Recovery and
      Recycling

      Consolidated

      Operating income (loss)

      38

      21

      (92)

      (47)

      (80)

      Depreciation and amortization

      30

      5

      17

      10

      62

      Impairment charges

      59

      1

      92

      —

      152

      Gain on acquisitions, disposals and others

      —

      —

      (2)

      —

      (2)

      Restructuring costs

      —

      —

      1

      —

      1

      Unrealized loss (gain) on derivative financial instruments

      (1)

      —

      —

      2

      1

      EBITDA (A)

      126

      27

      16

      (35)

      134


      For the 3-month period ended March 31, 2022

      (in millions of Canadian dollars) (unaudited)

      Containerboard

      Specialty
      Products

      Tissue
      Papers

      Corporate
      Activities,
      Recovery and
      Recycling

      Consolidated

      Operating income (loss)

      44

      24

      (35)

      (37)

      (4)

      Depreciation and amortization

      28

      4

      17

      11

      60

      Gain on acquisitions, disposals and others

      —

      (6)

      —

      —

      (6)

      Restructuring costs

      —

      —

      1

      —

      1

      Unrealized loss (gain) on derivative financial instruments

      8

      —

      —

      (1)

      7

      EBITDA (A)

      80

      22

      (17)

      (27)

      58


      PAYMENTS FOR PROPERTY, PLANT
      AND EQUIPMENT


      For the 3-month periods ended
      March 31,

      (in millions of Canadian dollars) (unaudited)

      2023

      2022

      Packaging Products



      Containerboard

      89

      75

      Specialty Products

      4

      11


      93

      86

      Tissue Papers

      9

      5

      Corporate Activities, Recovery and Recycling

      3

      8

      Total acquisitions

      105

      99

      Right-of-use assets acquisitions

      (8)

      (21)


      97

      78

      Acquisitions for property, plant and equipment included in "Trade and other payables"



      Beginning of the period

      106

      75

      End of the period

      (63)

      (51)

      Payments for property, plant and equipment

      140

      102

      Proceeds from disposals of property, plant and equipment

      (3)

      (6)

      Payments for property, plant and equipment net of proceeds from disposals

      137

      96


      SUPPLEMENTAL INFORMATION ON NON-IFRS MEASURES AND OTHER FINANCIAL MEASURES

      SPECIFIC ITEMS
      The Corporation incurs some specific items that adversely or positively affect its operating results. We believe it is useful for readers to be aware of these items as they provide additional information to measure performance, compare the Corporation's results between periods, and assess operating results and liquidity, notwithstanding these specific items. Management believes these specific items are not necessarily reflective of the Corporation's underlying business operations in measuring and comparing its performance and analyzing future trends. Our definition of specific items may differ from that of other corporations and some of these items may arise in the future and may reduce the Corporation's available cash.

      They include, but are not limited to, charges for (reversals of) impairment of assets, restructuring gains or costs, loss on refinancing and repurchase of long-term debt, some deferred tax asset provisions or reversals, premiums paid on repurchase of long-term debt, gains or losses on the acquisition or sale of a business unit, gains or losses on the share of results of associates and joint ventures, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps and option fair value revaluation, foreign exchange gains or losses on long-term debt and financial instruments, fair value revaluation gains or losses on investments, specific items of discontinued operations and other significant items of an unusual, non-cash or non-recurring nature.

      RECONCILIATION AND USES OF NON-IFRS AND OTHER FINANCIAL MEASURES

      To provide more information for evaluating the Corporation's performance, the financial information included in this analysis contains certain data that are not performance measures under IFRS ("non-IFRS measures"), which are also calculated on an adjusted basis to exclude specific items. We believe that providing certain key performance and capital measures, as well as non-IFRS measures, is useful to both Management and investors, as they provide additional information to measure the performance and financial position of the Corporation. This also increases the transparency and clarity of the financial information. The following non-IFRS measures and other financial measures are used in our financial disclosures:

      Non-IFRS measures

      • Adjusted earnings before interest, taxes, depreciation and amortization or EBITDA (A): represents the operating income before depreciation and amortization excluding specific items. Used to assess recurring operating performance and the contribution of each segment on a comparable basis.
      • Adjusted net earnings: Used to assess the Corporation's consolidated financial performance on a comparable basis.
      • Adjusted cash flow: Used to assess the Corporation's capacity to generate cash flows to meet financial obligations and/or discretionary items such as share repurchase, dividend increase and strategic investments.
      • Free cash flow: Used to measure the excess cash the Corporation generates by subtracting capital expenditures (excluding strategic projects) from the EBITDA (A).
      • Working capital: Used to assess the short-term liquidity of the Corporation.

      Other financial measures

      • Total debt: Used to calculate all the Corporation's debt, including long-term debt and bank loans. Often put in relation to equity to calculate the debt-to-equity ratio.
      • Net debt: Used to calculate the Corporation's total debt less cash and cash equivalents. Often put in relation to EBITDA (A) to calculate net debt to EBITDA (A) ratio.

      Non-IFRS ratios

      • Net debt to EBITDA (A) ratio: Used to assess the Corporation's ability to pay its debt and evaluate financial leverage.
      • EBITDA (A) margin: Used to assess operating performance and the contribution of each segment on a comparable basis calculated as a percentage of sales.
      • Adjusted net earnings per common share: Used to assess the Corporation's consolidated financial performance on a comparable basis.
      • Net debt / Net debt + Shareholders' equity: Used to evaluate the Corporation's financial leverage and thus the risk to Shareholders.
      • Working capital as a percentage of sales: Used to assess the Corporation's operating liquidity performance.
      • Adjusted cash flow per common share: Used to assess the Corporation's financial flexibility.
      • Free cash flow ratio: Used to measure the liquidity and efficiency of how much more cash the Corporation generates than it uses to run the business by subtracting capital expenditures (excluding strategic projects) from the EBITDA (A) calculated as a percentage of sales.

      Non-IFRS and other financial measures are mainly derived from the consolidated financial statements, but do not have meanings prescribed by IFRS. These measures have limitations as an analytical tool and should not be considered on their own or as a substitute for an analysis of our results as reported under IFRS. In addition, our definitions of non-IFRS and other financial measures may differ from those of other corporations. Any such modification or reformulation may be significant.

      The CODM assesses the performance of each reportable segment based on sales and earnings before interest, taxes, depreciation and amortization, adjusted to exclude specific items (EBITDA (A)1). The CODM considers EBITDA (A)1 to be the best performance measure of the Corporation's activities.

      EBITDA (A)1 by business segment is reconciled to IFRS measure, namely operating income (loss), and is presented in the following table:


      Q1 2023

      (in millions of Canadian dollars) (unaudited)

      Containerboard

      Specialty
      Products

      Tissue
      Papers

      Corporate
      Activities,
      Recovery and
      Recycling

      Consolidated

      Operating income (loss)

      38

      21

      (92)

      (47)

      (80)

      Depreciation and amortization

      30

      5

      17

      10

      62

      Impairment charges

      59

      1

      92

      —

      152

      Gain on acquisitions, disposals and others

      —

      —

      (2)

      —

      (2)

      Restructuring costs

      —

      —

      1

      —

      1

      Unrealized loss (gain) on derivative financial instruments

      (1)

      —

      —

      2

      1

      EBITDA (A)1

      126

      27

      16

      (35)

      134


      Q4 2022

      (in millions of Canadian dollars) (unaudited)

      Containerboard

      Specialty
      Products

      Tissue Papers

      Corporate
      Activities,
      Recovery and
      Recycling

      Consolidated

      Operating income (loss)

      85

      22

      (86)

      (41)

      (20)

      Depreciation and amortization

      30

      5

      17

      10

      62

      Impairment charges

      8

      3

      75

      —

      86

      Gain on acquisitions, disposals and others

      —

      (10)

      —

      —

      (10)

      Restructuring costs

      —

      —

      2

      —

      2

      Unrealized gain on derivative financial instruments

      (4)

      —

      —

      —

      (4)

      EBITDA (A)1

      119

      20

      8

      (31)

      116


      Q1 2022

      (in millions of Canadian dollars) (unaudited)

      Containerboard

      Specialty
      Products

      Tissue Papers

      Corporate
      Activities,
      Recovery and
      Recycling

      Consolidated

      Operating income (loss)

      44

      24

      (35)

      (37)

      (4)

      Depreciation and amortization

      28

      4

      17

      11

      60

      Gain on acquisitions, disposals and others

      —

      (6)

      —

      —

      (6)

      Restructuring costs

      —

      —

      1

      —

      1

      Unrealized loss (gain) on derivative financial instruments

      8

      —

      —

      (1)

      7

      EBITDA (A)1

      80

      22

      (17)

      (27)

      58

      1 Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation.


      The following table reconciles net loss and net loss per common share, as reported, with adjusted net earnings (loss)1 and adjusted net earnings (loss)1 per common share:

      (in millions of Canadian dollars, except per common share amounts and number of common shares) (unaudited)

      NET EARNINGS (LOSS)


      NET EARNINGS (LOSS)

      PER COMMON SHARE2


      Q1 2023

      Q4 2022

      Q1 2022


      Q1 2023

      Q4 2022

      Q1 2022

      As reported

      (75)

      (27)

      (15)


      ($0.75)

      ($0.27)

      ($0.15)

      Specific items:








      Impairment charges

      152

      86

      —


      $1.14

      $0.64

      —

      Gain on acquisitions, disposals and others

      (2)

      (10)

      (6)


      ($0.01)

      ($0.09)

      ($0.05)

      Restructuring costs

      1

      2

      1


      $0.01

      $0.02

      $0.01

      Unrealized loss (gain) on derivative financial instruments

      1

      (4)

      7


      —

      ($0.03)

      $0.05

      Foreign exchange gain on long-term debt and financial instruments

      —

      (3)

      (1)


      —

      ($0.02)

      ($0.01)

      Share of results of associates and joint ventures

      (9)

      —

      —


      ($0.07)

      —

      —

      Tax effect on specific items, other tax adjustments and attributable to non-controlling interest2

      (35)

      (22)

      (1)


      —

      ($0.03)

      —


      108

      49

      —


      $1.07

      $0.49

      —

      Adjusted1

      33

      22

      (15)


      $0.32

      $0.22

      ($0.15)

      Weighted average basic number of common shares outstanding





      100,361,627

      100,361,627

      100,822,921


      The following table reconciles cash flow from (used by) operating activities with EBITDA (A)1:

      (in millions of Canadian dollars) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022

      Cash flow from (used by) operating activities

      43

      196

      (73)

      Changes in non-cash working capital components

      46

      (96)

      92

      Net income taxes paid

      2

      —

      1

      Net financing expense paid

      44

      15

      30

      Provisions for contingencies and charges and other liabilities, net of dividends received

      (1)

      1

      8

      EBITDA (A)1

      134

      116

      58


      The following table reconciles cash flow from (used by) operating activities with cash flow from operating activities (excluding changes in non-cash working capital components) and adjusted cash flow from operating activities. It also reconciles adjusted cash flow from operating activities1 to adjusted cash flow used1, which is also calculated on a per common share basis:

      (in millions of Canadian dollars, except per common share amounts or otherwise noted) (unaudited)

      Q1 2023

      Q4 2022

      Q1 2022

      Cash flow from (used by) operating activities

      43

      196

      (73)

      Changes in non-cash working capital components

      46

      (96)

      92

      Cash flow from operating activities (excluding changes in non-cash working capital components)

      89

      100

      19

      Restructuring costs paid

      1

      3

      7

      Adjusted cash flow from operating activities1

      90

      103

      26

      Payments for property, plant and equipment

      (140)

      (160)

      (102)

      Change in intangible and other assets

      (2)

      (2)

      (1)

      Lease obligation payments

      (14)

      (15)

      (13)

      Proceeds from disposals of property, plant and equipment

      3

      11

      6


      (63)

      (63)

      (84)

      Dividends paid to non-controlling interests

      (3)

      (4)

      (4)

      Dividends paid to the Corporation's Shareholders and to non-controlling interests

      (12)

      (12)

      (12)

      Adjusted cash flow used1

      (78)

      (79)

      (100)

      Adjusted cash flow used1 per common share

       (in Canadian dollars)

      ($0.78)

      ($0.79)

      ($0.99)

      Weighted average basic number of common shares outstanding

      100,361,627

      100,361,627

      100,822,921

      1 Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation.

      2 Specific amounts per common share are calculated on an after-tax basis and are net of the portion attributable to non-controlling interests. Per share amounts in line item ''Tax effect on specific items, other tax adjustments and attributable to non-controlling interests'' only include the effect of tax adjustments.


      The following table reconciles total debt1 and net debt1 with the ratio of net debt to adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A))1:

      (in millions of Canadian dollars) (unaudited)

      March31,

      2023

      December 31,

       2022

      March 31,

      2022

      Long-term debt

      2,044

      1,931

      1,510

      Current portion of long-term debt

      88

      134

      69

      Bank loans and advances

      2

      3

      7

      Total debt1

      2,134

      2,068

      1,586

      Less: Cash and cash equivalents

      (64)

      (102)

      (37)

      Net debt1 as reported

      2,070

      1,966

      1,549

      Last twelve months EBITDA (A)1

      452

      376

      325

      Net debt / EBITDA (A) ratio1

                    4.6x

                    5.2x

                    4.8x

      1 Please refer to the "Supplemental Information on Non-IFRS Measures and Other Financial Measures" section for a complete reconciliation.

      SOURCE Cascades Inc.

      Modal title

      Also from this source

      Cascades Announces the Retirement of Vice-President and Chief Financial Officer Allan Hogg in the Second Half of 2027

      Cascades Announces the Retirement of Vice-President and Chief Financial Officer Allan Hogg in the Second Half of 2027

      Cascades inc. (TSX: CAS), announces that its Vice-President and Chief Financial Officer, Allan Hogg, will retire in the second half of 2027,...

      Cascades Reports Third Quarter 2026 Results

      Cascades Reports Third Quarter 2026 Results

      Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2026. Q3 2026 Highlights Sales of...

      More Releases From This Source

      Explore

      Paper, Forest Products & Containers

      Paper, Forest Products & Containers

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.